GC Biopharma Corp. Preliminary Earnings
GAI summary · Not investment advice
GC Biopharma's Q3 2026 consolidated revenue was KRW 522.1 billion, down 14.3% year over year and up 24.0% quarter over quarter; operating profit was KRW 49.2 billion, up 68.5% year over year.
Operating profit · current quarter
KRW 49.2 billion
Key facts
- Basis
- Consolidated
- Revenue (current quarter)
- KRW 522.1 billion
- Revenue (previous quarter)
- KRW 421.2 billion
- Revenue (prior-year quarter)
- KRW 609.5 billion
- Revenue change vs. previous quarter
- 24.0%
- Revenue change vs. prior-year quarter
- -14.3%
- Revenue (year to date)
- KRW 1.4 trillion
- Operating profit (previous quarter)
- KRW 1.7 billion
- Operating profit (prior-year quarter)
- KRW 29.2 billion
- Operating profit change vs. previous quarter
- 2,794.1%
- Operating profit change vs. prior-year quarter
- 68.5%
- Operating profit (year to date)
- KRW 62.7 billion
- Net income (current quarter)
- KRW 208.5 billion
- Net income (previous quarter)
- KRW 1.1 billion
- Net income (prior-year quarter)
- KRW 18.1 billion
- Net income change vs. previous quarter
- 18,854.5%
- Net income change vs. prior-year quarter
- 1,051.9%
- Net income (year to date)
- KRW 229.7 billion
- Net income attributable to owners (current quarter)
- KRW 222.2 billion
Commentary
AI commentary · Not investment advice
What happened
GC Corp (Green Cross) disclosed its preliminary consolidated results for the third quarter of 2026 as a fair disclosure, filed on November 2, 2026. Revenue for the quarter was KRW 522.1 billion, operating profit was KRW 49.2 billion, and net profit was KRW 208.5 billion. Net profit attributable to owners of the parent was KRW 222.2 billion. Cumulative revenue was KRW 1,378.9 billion, cumulative operating profit was KRW 62.7 billion, and cumulative net profit was KRW 229.7 billion.
In the company's terms
Revenue rose 24.0% from the previous quarter's KRW 421.2 billion and fell 14.3% from KRW 609.5 billion a year earlier. Operating profit rose 2,794.1% from KRW 1.7 billion in the previous quarter and 68.5% from KRW 29.2 billion a year earlier. Net profit rose 18,854.5% from KRW 1.1 billion in the previous quarter and 1,051.9% from KRW 18.1 billion a year earlier. The materials list the figure at 3.2% relative to market capitalization.
Show Korean comments
Comments
No comments yet
Comments from shareholders will appear here.
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist